These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [Neurodegenerative disorders: review of current classification and diagnostic neuropathological criteria]. Matej R; Rusina R Cesk Patol; 2012 Apr; 48(2):83-90. PubMed ID: 22716055 [TBL] [Abstract][Full Text] [Related]
28. TDP-43 proteinopathies: neurodegenerative protein misfolding diseases without amyloidosis. Kwong LK; Uryu K; Trojanowski JQ; Lee VM Neurosignals; 2008; 16(1):41-51. PubMed ID: 18097159 [TBL] [Abstract][Full Text] [Related]
29. Valosin-containing protein immunoreactivity in tauopathies, synucleinopathies, polyglutamine diseases and intranuclear inclusion body disease. Mori F; Tanji K; Toyoshima Y; Sasaki H; Yoshida M; Kakita A; Takahashi H; Wakabayashi K Neuropathology; 2013 Dec; 33(6):637-44. PubMed ID: 23782134 [TBL] [Abstract][Full Text] [Related]
30. Tauopathies and tau oligomers. Takashima A J Alzheimers Dis; 2013; 37(3):565-8. PubMed ID: 23948895 [TBL] [Abstract][Full Text] [Related]
31. Are comorbidities compatible with a molecular pathological classification of neurodegenerative diseases? Kovacs GG Curr Opin Neurol; 2019 Apr; 32(2):279-291. PubMed ID: 30672825 [TBL] [Abstract][Full Text] [Related]
32. Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine. Kovacs GG Int J Mol Sci; 2016 Feb; 17(2):. PubMed ID: 26848654 [TBL] [Abstract][Full Text] [Related]
33. Spreading of pathology in neurodegenerative diseases: a focus on human studies. Brettschneider J; Del Tredici K; Lee VM; Trojanowski JQ Nat Rev Neurosci; 2015 Feb; 16(2):109-20. PubMed ID: 25588378 [TBL] [Abstract][Full Text] [Related]
34. Accumulation of the sigma-1 receptor is common to neuronal nuclear inclusions in various neurodegenerative diseases. Miki Y; Mori F; Kon T; Tanji K; Toyoshima Y; Yoshida M; Sasaki H; Kakita A; Takahashi H; Wakabayashi K Neuropathology; 2014 Apr; 34(2):148-58. PubMed ID: 24313828 [TBL] [Abstract][Full Text] [Related]
35. Alpha-synuclein and tau: teammates in neurodegeneration? Moussaud S; Jones DR; Moussaud-Lamodière EL; Delenclos M; Ross OA; McLean PJ Mol Neurodegener; 2014 Oct; 9():43. PubMed ID: 25352339 [TBL] [Abstract][Full Text] [Related]
36. Sequestration of cellular interacting partners by protein aggregates: implication in a loss-of-function pathology. Yang H; Hu HY FEBS J; 2016 Oct; 283(20):3705-3717. PubMed ID: 27016044 [TBL] [Abstract][Full Text] [Related]
38. Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain. Wakabayashi K; Mori F; Tanji K; Orimo S; Takahashi H Acta Neuropathol; 2010 Jul; 120(1):1-12. PubMed ID: 20532896 [TBL] [Abstract][Full Text] [Related]